Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone
Background: This study investigated the value of adding Ismigen ® , a polyvalent mechanical bacterial lysate, to therapy of COPD patients (FEV 1 <60% predicted) under regular treatment with salmeterol/fluticasone (SFC). Methods: 63 patients enrolled from September to December 2007 were randomly d...
Main Authors: | Mario Cazzola, Paolo Noschese, Felice Di Perna |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-04-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465809104677 |
Similar Items
-
The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
by: Barbara P Yawn, et al.
Published: (2010-06-01) -
Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
by: Beatrix Balint, et al.
Published: (2010-09-01) -
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD
by: Martyn R. Partridge, et al.
Published: (2009-08-01) -
Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD
by: Gao J, et al.
Published: (2015-04-01) -
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
by: Anzueto AR, et al.
Published: (2017-05-01)